TARO logo

TARO Working Capital

TARO Annual Working Capital

$942.30 M
-$8.58 M-0.90%

31 March 2024

TARO Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TARO Quarterly Working Capital

$942.30 M
-$31.05 M-3.19%

31 March 2024

TARO Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TARO Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-0.9%-3.2%
3 y3 years+18.6%+18.6%
5 y5 years-25.6%-24.2%

TARO Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time-47.3%-47.3%

Taro Pharmaceutical Industries Working Capital History

DateAnnualQuarterly
Mar 2024
$942.30 M(-0.9%)
$942.30 M(-3.2%)
Dec 2023
-
$973.35 M(-0.8%)
Sept 2023
-
$981.07 M(+7.9%)
June 2023
-
$909.17 M(-4.4%)
Mar 2023
$950.88 M(+5.0%)
$950.88 M(-3.1%)
Sept 2022
-
$981.76 M(+0.8%)
June 2022
-
$973.82 M(+7.5%)
Mar 2022
$905.77 M(+14.0%)
$905.77 M(+7.5%)
Dec 2021
-
$842.45 M(+5.6%)
Sept 2021
-
$797.99 M(+6.2%)
June 2021
-
$751.62 M(-5.4%)
Mar 2021
$794.53 M(-39.3%)
$794.53 M(-15.3%)
Dec 2020
-
$938.20 M(+4.4%)
Sept 2020
-
$898.51 M(-3.0%)
June 2020
-
$926.45 M(-29.3%)
Mar 2020
$1.31 B(+3.5%)
$1.31 B(+5.3%)
Dec 2019
-
$1.24 B(-2.1%)
Sept 2019
-
$1.27 B(-5.5%)
June 2019
-
$1.34 B(+6.2%)
Mar 2019
$1.27 B(-24.7%)
$1.27 B(+1.8%)
Dec 2018
-
$1.24 B(-25.2%)
Sept 2018
-
$1.66 B(+1.3%)
June 2018
-
$1.64 B(-2.4%)
Mar 2018
$1.68 B(-6.1%)
$1.68 B(-0.7%)
Dec 2017
-
$1.69 B(-1.9%)
Sept 2017
-
$1.73 B(-0.2%)
June 2017
-
$1.73 B(-3.4%)
Mar 2017
$1.79 B(+9.6%)
$1.79 B(+16.0%)
Dec 2016
-
$1.54 B(+14.0%)
Sept 2016
-
$1.35 B(-6.2%)
June 2016
-
$1.44 B(-11.7%)
Mar 2016
$1.63 B(+35.6%)
$1.63 B(+3.6%)
Dec 2015
-
$1.57 B(+9.9%)
Sept 2015
-
$1.43 B(+8.4%)
June 2015
-
$1.32 B(+9.8%)
Mar 2015
$1.20 B(+50.9%)
$1.20 B(+10.9%)
Dec 2014
-
$1.09 B(+10.7%)
Sept 2014
-
$980.08 M(+16.1%)
June 2014
-
$844.22 M(+5.8%)
Mar 2014
$797.97 M(+11.3%)
$797.97 M(+8.7%)
Dec 2013
-
$734.43 M(-15.5%)
Sept 2013
-
$868.98 M(+13.7%)
June 2013
-
$764.11 M(+6.5%)
Mar 2013
$717.24 M(+57.7%)
$717.24 M(+7.4%)
Dec 2012
-
$667.83 M(+11.6%)
Sept 2012
-
$598.63 M(+15.0%)
June 2012
-
$520.61 M(+14.5%)
Mar 2012
$454.76 M(+16.3%)
$454.76 M(+16.3%)
Dec 2011
$391.05 M(+135.8%)
$391.05 M(+24.1%)
Sept 2011
-
$315.23 M(+19.8%)
June 2011
-
$263.15 M(+25.1%)
Mar 2011
-
$210.28 M(+26.8%)
Dec 2010
$165.85 M(+180.7%)
$165.85 M(+38.8%)
Sept 2010
-
$119.45 M(+50.5%)
June 2010
-
$79.36 M(+34.3%)
Dec 2009
$59.09 M
$59.09 M(+6.6%)
Sept 2009
-
$55.45 M(+8.1%)
June 2009
-
$51.30 M(+8.1%)
DateAnnualQuarterly
Mar 2009
-
$47.44 M(-471.4%)
Dec 2008
-$12.77 M(-47.8%)
-$12.77 M(-133.4%)
Sept 2008
-
$38.25 M(-172.3%)
Dec 2007
-$24.45 M(-81.2%)
-
Dec 2006
-$130.18 M(+146.2%)
-
Dec 2005
-$52.87 M(-126.2%)
-$52.87 M(-127.0%)
Sept 2005
-
$195.47 M(+5.1%)
June 2005
-
$185.94 M(+0.1%)
Mar 2005
-
$185.74 M(-7.9%)
Dec 2004
$201.59 M(-28.0%)
$201.59 M(-1.9%)
Sept 2004
-
$205.53 M(-14.9%)
June 2004
-
$241.49 M(-7.9%)
Mar 2004
-
$262.07 M(-6.4%)
Dec 2003
$279.95 M(+40.8%)
$279.95 M(+19.5%)
Sept 2003
-
$234.22 M(+0.3%)
June 2003
-
$233.50 M(+31.4%)
Mar 2003
-
$177.75 M(-10.6%)
Dec 2002
$198.87 M(+1.1%)
$198.87 M(+0.7%)
Sept 2002
-
$197.58 M(-0.6%)
June 2002
-
$198.70 M(-2.1%)
Mar 2002
-
$202.93 M(+3.2%)
Dec 2001
$196.71 M(+351.3%)
$196.71 M(+210.2%)
Sept 2001
-
$63.42 M(+12.4%)
June 2001
-
$56.44 M(+26.9%)
Mar 2001
-
$44.47 M(+2.0%)
Dec 2000
$43.59 M(+67.9%)
$43.59 M(+19.0%)
Sept 2000
-
$36.64 M(+30.5%)
June 2000
-
$28.08 M(+12.4%)
Mar 2000
-
$24.99 M(-3.8%)
Dec 1999
$25.96 M(+118.2%)
$25.96 M(+7.7%)
Sept 1999
-
$24.10 M(+68.5%)
June 1999
-
$14.30 M(+11.7%)
Mar 1999
-
$12.80 M(+7.6%)
Dec 1998
$11.90 M(+14.4%)
$11.90 M(+26.6%)
Mar 1998
-
$9.40 M(-9.6%)
Dec 1997
$10.40 M(-18.8%)
$10.40 M(-21.8%)
Sept 1997
-
$13.30 M(+4.7%)
June 1997
-
$12.70 M(+0.8%)
Mar 1997
-
$12.60 M(-1.6%)
Dec 1996
$12.80 M(-11.1%)
$12.80 M(-7.9%)
Sept 1996
-
$13.90 M(-4.1%)
June 1996
-
$14.50 M(0.0%)
Mar 1996
-
$14.50 M(+0.7%)
Dec 1995
$14.40 M(+136.1%)
$14.40 M(+136.1%)
Dec 1994
$6.10 M(+45.2%)
$6.10 M(+45.2%)
Dec 1993
$4.20 M(+5.0%)
$4.20 M(+5.0%)
Dec 1992
$4.00 M(+21.2%)
$4.00 M(-29.8%)
Sept 1992
-
$5.70 M(-6.6%)
June 1992
-
$6.10 M(-1.6%)
Mar 1992
-
$6.20 M(+87.9%)
Dec 1991
$3.30 M(+153.8%)
$3.30 M(+94.1%)
Sept 1991
-
$1.70 M(+21.4%)
June 1991
-
$1.40 M(-22.2%)
Mar 1991
-
$1.80 M(+38.5%)
Dec 1990
$1.30 M(-13.3%)
$1.30 M(0.0%)
Mar 1990
-
$1.30 M(-13.3%)
Dec 1989
$1.50 M(-16.7%)
$1.50 M(-16.7%)
Dec 1988
$1.80 M(0.0%)
$1.80 M(0.0%)
Dec 1987
$1.80 M
$1.80 M

FAQ

  • What is Taro Pharmaceutical Industries annual working capital?
  • What is the all time high annual working capital for Taro Pharmaceutical Industries?
  • What is Taro Pharmaceutical Industries annual working capital year-on-year change?
  • What is Taro Pharmaceutical Industries quarterly working capital?
  • What is the all time high quarterly working capital for Taro Pharmaceutical Industries?
  • What is Taro Pharmaceutical Industries quarterly working capital year-on-year change?

What is Taro Pharmaceutical Industries annual working capital?

The current annual working capital of TARO is $942.30 M

What is the all time high annual working capital for Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries all-time high annual working capital is $1.79 B

What is Taro Pharmaceutical Industries annual working capital year-on-year change?

Over the past year, TARO annual working capital has changed by -$8.58 M (-0.90%)

What is Taro Pharmaceutical Industries quarterly working capital?

The current quarterly working capital of TARO is $942.30 M

What is the all time high quarterly working capital for Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries all-time high quarterly working capital is $1.79 B

What is Taro Pharmaceutical Industries quarterly working capital year-on-year change?

Over the past year, TARO quarterly working capital has changed by -$31.05 M (-3.19%)